FORTRESS BIOTECH INC (FBIO) Stock Price & Overview
NASDAQ:FBIO • US34960Q3074
Current stock price
The current stock price of FBIO is 2.43 USD. Today FBIO is up by 0.41%. In the past month the price decreased by -22.12%. In the past year, price increased by 58.82%.
FBIO Key Statistics
- Market Cap
- 78.246M
- P/E
- N/A
- Fwd P/E
- 238.24
- EPS (TTM)
- -0.88
- Dividend Yield
- N/A
FBIO Stock Performance
FBIO Stock Chart
FBIO Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to FBIO. When comparing the yearly performance of all stocks, FBIO turns out to be only a medium performer in the overall market: it outperformed 59.01% of all stocks.
FBIO Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to FBIO. FBIO may be in some trouble as it scores bad on both profitability and health.
FBIO Earnings
On March 31, 2026 FBIO reported an EPS of -0.01 and a revenue of 16.08M. The company missed EPS expectations (-108.91% surprise) and missed revenue expectations (-39.76% surprise).
FBIO Forecast & Estimates
8 analysts have analysed FBIO and the average price target is 10.97 USD. This implies a price increase of 351.23% is expected in the next year compared to the current price of 2.43.
For the next year, analysts expect an EPS growth of 101.16% and a revenue growth 49.34% for FBIO
FBIO Groups
Sector & Classification
FBIO Financial Highlights
Over the last trailing twelve months FBIO reported a non-GAAP Earnings per Share(EPS) of -0.88. The EPS increased by 73.09% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.01% | ||
| ROE | -3.78% | ||
| Debt/Equity | 1.19 |
FBIO Ownership
FBIO Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.05 | 368.645B | ||
| AMGN | AMGEN INC | 15.25 | 187.715B | ||
| GILD | GILEAD SCIENCES INC | 15.81 | 173.485B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.68 | 112.351B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.08 | 79.706B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 48.84 | 44.214B | ||
| INSM | INSMED INC | N/A | 31.674B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 30.229B | ||
| NTRA | NATERA INC | N/A | 29.365B | ||
| BIIB | BIOGEN INC | 11.2 | 26.496B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.76 | 25.315B | ||
| MRNA | MODERNA INC | N/A | 21.519B | ||
| INCY | INCYTE CORP | 12.55 | 19.324B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About FBIO
Company Profile
Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. The company is headquartered in Bay Harbor Islands, Florida and currently employs 101 full-time employees. The company went IPO on 2011-11-17. The firm has eight marketed prescription pharmaceutical products and over 20 programs in development, with its majority-owned and majority-controlled partners and subsidiaries and partners and subsidiaries it founded and in which it holds significant minority ownership positions. Its portfolio is being commercialized and developed for various therapeutic areas, including oncology, dermatology, and rare diseases. Its dermatology products include Emrosi, Qbrexza, Amzeeq, Zilxi, Exelderm, Targadox, and Luxamend. Its late-stage product candidates include CUTX-101 (copper histidinate injection for Menkes disease), Triplex (cytomegalovirus (CMV) vaccine), and CAEL-101 (monoclonal antibody for AL amyloidosis). Its early and mid-stage product candidates include Dotinurad (urate transporter (URAT1) inhibitor for gout), MB-101 (IL13Rα2 CAR T Cell Program for Glioblastoma), and others.
Company Info
IPO: 2011-11-17
FORTRESS BIOTECH INC
1111 Kane Concourse, Suite 301
Bay Harbor Islands FLORIDA 10014 US
CEO: Lindsay A. Rosenwald
Employees: 101
Phone: 17816524500
FORTRESS BIOTECH INC / FBIO FAQ
What does FBIO do?
Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. The company is headquartered in Bay Harbor Islands, Florida and currently employs 101 full-time employees. The company went IPO on 2011-11-17. The firm has eight marketed prescription pharmaceutical products and over 20 programs in development, with its majority-owned and majority-controlled partners and subsidiaries and partners and subsidiaries it founded and in which it holds significant minority ownership positions. Its portfolio is being commercialized and developed for various therapeutic areas, including oncology, dermatology, and rare diseases. Its dermatology products include Emrosi, Qbrexza, Amzeeq, Zilxi, Exelderm, Targadox, and Luxamend. Its late-stage product candidates include CUTX-101 (copper histidinate injection for Menkes disease), Triplex (cytomegalovirus (CMV) vaccine), and CAEL-101 (monoclonal antibody for AL amyloidosis). Its early and mid-stage product candidates include Dotinurad (urate transporter (URAT1) inhibitor for gout), MB-101 (IL13Rα2 CAR T Cell Program for Glioblastoma), and others.
What is the stock price of FORTRESS BIOTECH INC today?
The current stock price of FBIO is 2.43 USD. The price increased by 0.41% in the last trading session.
Does FBIO stock pay dividends?
FBIO does not pay a dividend.
What is the ChartMill rating of FORTRESS BIOTECH INC stock?
FBIO has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Is FORTRESS BIOTECH INC (FBIO) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on FBIO.
Can you provide the ownership details for FBIO stock?
You can find the ownership structure of FORTRESS BIOTECH INC (FBIO) on the Ownership tab.